Completed

TRANSPAutologous Pulp Transplantation for Necrotic Mature Teeth with Periapical Radiolucency

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to evaluate if using your own pulp for transplantation can restore vitality in mature teeth with necrotic tissue and periapical radiolucency.

What is being tested

Conventional root canal therapy

+ Autologous dental pulp transplantation

+ Pulp transplantation with CGF

Procedure
Who is being recruted

From 18 to 40 Years
+12 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: November 2023
See protocol details

Summary

Principal SponsorKahramanmaras Sutcu Imam University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: November 5, 2023

Actual date on which the first participant was enrolled.

This clinical study is exploring a new way to treat mature teeth that have become necrotic, which means the tooth's nerve tissue is dead, and there is an area of bone loss at the root's tip, known as periapical radiolucency. The research is focused on using a person's own dental pulp tissue, possibly combined with a concentrated growth factor, as a biologic alternative to traditional root canal treatments. This approach could help regenerate tissue and restore the function of these affected teeth. This study is important because it may offer a more natural and potentially more effective option for dental patients with this specific problem. Participants in this study are adults with single-rooted teeth that have been diagnosed with pulp necrosis and periapical issues. They are randomly assigned to one of three treatment groups: one receiving only pulp transplantation, another receiving pulp transplantation plus a growth factor, and the third undergoing a standard root canal. The pulp tissue for transplantation is carefully taken from the patient's own non-damaged wisdom teeth. Throughout the study, the success of the treatments is measured by checking the vitality of the pulp using an electric pulp test and through X-ray images at various follow-up times. This study aims to gather essential evidence on whether these new methods are safe and effective for future dental treatments.

Official TitlePulp Transplantation in Necrotic Mature Teeth With Periapical Radiolucency
NCT07258888
Principal SponsorKahramanmaras Sutcu Imam University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

21 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 40 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

5 inclusion criteria required to participate
Adults aged 18-40 years

Presence of single-rooted permanent teeth diagnosed with pulp necrosis or irreversible pulpitis associated with radiographic periapical lesions

Availability of a caries-free, periodontally healthy third molar suitable for donor pulp harvesting

Good general health (no systemic diseases)

Show More Criteria

7 exclusion criteria prevent from participating
Lack of a suitable donor third molar for pulp harvesting

Multi-rooted teeth or teeth with complex canal anatomy

Systemic diseases or medical conditions that may affect wound healing (e.g., diabetes, immunosuppression)

Advanced periodontal attachment loss or active periodontal disease

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups

3 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Active Comparator
Patients undergo standard root canal preparation and obturation with gutta-percha and sealer using lateral condensation, followed by restoration.

Group II

Active Comparator
Harvest of autologous third-molar pulp; canal disinfection; transplantation; MTA coronal seal; restoration.

Group III

Active Comparator
Same as pulp transplantation with the addition of autologous concentrated growth factor (CGF) placed over the transplanted pulp prior to MTA seal.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

ahramanmaraş Sütçü İmam University, Faculty of Dentistry

Kahramanmaraş, Turkey (Türkiye)Open ahramanmaraş Sütçü İmam University, Faculty of Dentistry in Google Maps
CompletedOne Study Center